دورية أكاديمية

Methods in DNA methylation profiling.

التفاصيل البيبلوغرافية
العنوان: Methods in DNA methylation profiling.
المؤلفون: Zuo T; Division of Human Cancer Genetics, Department of Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, Ohio State University, Columbus, OH 43210, USA. tim.huang@osumc.edu, Tycko B, Liu TM, Lin JJ, Huang TH
المصدر: Epigenomics [Epigenomics] 2009 Dec; Vol. 1 (2), pp. 331-45.
نوع المنشور: Journal Article; Review
اللغة: English
بيانات الدورية: Publisher: Future Medicine Country of Publication: England NLM ID: 101519720 Publication Model: Print Cited Medium: Internet ISSN: 1750-192X (Electronic) Linking ISSN: 1750192X NLM ISO Abbreviation: Epigenomics Subsets: MEDLINE
أسماء مطبوعة: Original Publication: London : Future Medicine, 2009-
مواضيع طبية MeSH: Biomarkers/*metabolism , DNA/*isolation & purification , DNA Methylation/*physiology , DNA Modification Methylases/*metabolism , Epigenomics/*methods , Gene Expression Profiling/*methods, Azacitidine/analogs & derivatives ; Chromatography, Affinity/methods ; DNA/metabolism ; DNA Methylation/drug effects ; DNA Methylation/genetics ; DNA Modification Methylases/pharmacology ; Decitabine ; Epigenomics/trends ; Mass Spectrometry/methods ; Microarray Analysis/methods ; Sequence Analysis, DNA/methods
مستخلص: Metastable and somatically heritable patterns of DNA methylation provide an important level of genomic regulation. In this article, we review methods for analyzing these genome-wide epigenetic patterns and offer a perspective on the ever-expanding literature, which we hope will be useful for investigators who are new to this area. The historical aspects that we cover will be helpful in interpreting this literature and we hope that our discussion of the newest analytical methods will stimulate future progress. We emphasize that no single approach can provide a complete view of the overall methylome, and that combinations of several modalities applied to the same sample set will give the clearest picture. Given the unexpected epigenomic patterns and new biological principles, as well as new disease markers, that have been uncovered in recent studies, it is likely that important discoveries will continue to be made using genome-wide DNA methylation profiling.
References: Nat Rev Genet. 2002 Jun;3(6):415-28. (PMID: 12042769)
Hum Mol Genet. 2001 Jun 15;10(13):1413-9. (PMID: 11440994)
Curr Mol Med. 2007 Feb;7(1):103-20. (PMID: 17311536)
Hum Mol Genet. 1999 Mar;8(3):459-70. (PMID: 9949205)
Oncogene. 2002 May 23;21(23):3804-13. (PMID: 12032849)
Nat Rev Genet. 2008 Jun;9(6):465-76. (PMID: 18463664)
Hum Mutat. 2006 Jun;27(6):589-96. (PMID: 16652338)
Proc Natl Acad Sci U S A. 2008 Jan 8;105(1):252-7. (PMID: 18162535)
Clin Cancer Res. 2007 Oct 15;13(20):6093-8. (PMID: 17947473)
J Hum Genet. 2006;51(4):368-374. (PMID: 16435073)
Hum Mol Genet. 2002 Oct 1;11(20):2479-88. (PMID: 12351584)
Genome Res. 2008 May;18(5):780-90. (PMID: 18316654)
Cancer Res. 2005 Dec 15;65(24):11241-6. (PMID: 16357125)
Nat Genet. 2006 Feb;38(2):149-53. (PMID: 16444255)
Oncology. 2003;64(2):124-30. (PMID: 12566909)
Nature. 2007 Jun 14;447(7146):799-816. (PMID: 17571346)
Nucleic Acids Res. 2005 May 23;33(9):2952-61. (PMID: 15911630)
Nat Rev Genet. 2004 Jun;5(6):446-55. (PMID: 15153997)
Cancer Res. 2006 Apr 1;66(7):3443-51. (PMID: 16585166)
Nat Genet. 2000 Feb;24(2):132-8. (PMID: 10655057)
Nat Genet. 2005 Aug;37(8):853-62. (PMID: 16007088)
Cancer Cell. 2004 Feb;5(2):121-5. (PMID: 14998488)
Proc Natl Acad Sci U S A. 1996 Sep 3;93(18):9821-6. (PMID: 8790415)
Nat Rev Cancer. 2004 Feb;4(2):143-53. (PMID: 14732866)
Nat Genet. 2009 Feb;41(2):178-186. (PMID: 19151715)
Nucleic Acids Res. 2002 Mar 1;30(5):e21. (PMID: 11861926)
Nucleic Acids Res. 2000 Apr 15;28(8):E32. (PMID: 10734209)
Genome Res. 2006 Feb;16(2):157-63. (PMID: 16365381)
Nature. 2008 Aug 7;454(7205):766-70. (PMID: 18600261)
Nat Genet. 2008 Jul;40(7):904-8. (PMID: 18568024)
Neoplasia. 2005 Aug;7(8):748-60. (PMID: 16207477)
Nature. 2008 Aug 7;454(7205):711-5. (PMID: 18685699)
N Engl J Med. 2008 Mar 13;358(11):1148-59. (PMID: 18337604)
N Biotechnol. 2009 Apr;25(4):195-203. (PMID: 19429539)
Trends Biochem Sci. 2006 Feb;31(2):89-97. (PMID: 16403636)
Nucleic Acids Res. 2005 Mar 10;33(5):e46. (PMID: 15760842)
Curr Protoc Mol Biol. 2008 Jan;Chapter 7:Unit 7.1. (PMID: 18231983)
Cancer Res. 2006 Jan 15;66(2):653-8. (PMID: 16423993)
Nature. 2008 Mar 6;452(7183):112-5. (PMID: 18322535)
Cancer Biomark. 2005;1(2-3):193-200. (PMID: 17192040)
J Mol Diagn. 2008 Jan;10(1):93-101. (PMID: 18165279)
Nat Genet. 2005 Jun;37(6):645-51. (PMID: 15895082)
Genome Res. 2002 Jan;12(1):158-64. (PMID: 11779841)
Science. 2003 Apr 18;300(5618):489-92. (PMID: 12702876)
Am J Pathol. 2003 Jul;163(1):37-45. (PMID: 12819009)
Cell Mol Life Sci. 2003 Aug;60(8):1647-58. (PMID: 14504655)
Cancer Res. 2006 Aug 15;66(16):7939-47. (PMID: 16912168)
Cancer Res. 2006 Nov 15;66(22):10911-8. (PMID: 17108128)
Cell. 2007 Feb 23;128(4):683-92. (PMID: 17320506)
Nat Biotechnol. 2009 Apr;27(4):353-60. (PMID: 19330000)
Science. 2007 Feb 23;315(5815):1141-3. (PMID: 17322062)
Cancer Res. 2001 Dec 1;61(23):8375-80. (PMID: 11731411)
EMBO J. 2003 Dec 1;22(23):6335-45. (PMID: 14633992)
Cancer Res. 2007 Sep 15;67(18):8511-8. (PMID: 17875690)
Proc Natl Acad Sci U S A. 2005 Nov 1;102(44):15785-90. (PMID: 16243968)
Nature. 2008 Mar 13;452(7184):215-9. (PMID: 18278030)
Hum Genet. 2007 Jan;120(5):701-11. (PMID: 17024368)
Nature. 2008 Mar 6;452(7183):45-50. (PMID: 18322525)
Cell. 1992 Nov 27;71(5):865-73. (PMID: 1423634)
Genome Res. 2006 Mar;16(3):383-93. (PMID: 16449502)
PLoS Biol. 2008 Jan;6(1):e22. (PMID: 18232738)
J Pharmacol Exp Ther. 2004 Dec;311(3):968-81. (PMID: 15302897)
Oncogene. 2006 May 18;25(21):3059-64. (PMID: 16407832)
Cancer Res. 2006 Jun 15;66(12):6118-28. (PMID: 16778185)
Nat Rev Drug Discov. 2006 Jan;5(1):37-50. (PMID: 16485345)
Clin Cancer Res. 2002 Jul;8(7):2246-52. (PMID: 12114427)
Nat Methods. 2005 Mar;2(3):219-24. (PMID: 16163803)
Cancer Res. 2007 May 15;67(10):4545-9. (PMID: 17510378)
J Nutr. 2002 Aug;132(8 Suppl):2430S-2434S. (PMID: 12163706)
Nat Biotechnol. 2008 Jul;26(7):779-85. (PMID: 18612301)
Int J Cancer. 2002 Dec 20;102(6):623-8. (PMID: 12448005)
Nat Genet. 2004 Mar;36(3):299-303. (PMID: 14981516)
Oncogene. 2002 Aug 12;21(35):5414-26. (PMID: 12154404)
Cell. 2008 Jun 27;133(7):1145-8. (PMID: 18585349)
Nucleic Acids Res. 2006 Jan 20;34(2):528-42. (PMID: 16428248)
Genome Res. 2006 Aug;16(8):1046-55. (PMID: 16809668)
Cell Stem Cell. 2008 Feb 7;2(2):123-34. (PMID: 18371433)
Nat Biotechnol. 2009 Apr;27(4):361-8. (PMID: 19329998)
J Cell Biochem. 2003 Jan 1;88(1):138-43. (PMID: 12461783)
Nucleic Acids Res. 1994 Aug 11;22(15):2990-7. (PMID: 8065911)
Cancer Res. 2004 Jun 1;64(11):3871-7. (PMID: 15172996)
Cancer Res. 2008 Dec 15;68(24):10257-66. (PMID: 19074894)
Ann N Y Acad Sci. 2003 Mar;983:120-30. (PMID: 12724217)
Annu Rev Biochem. 2005;74:481-514. (PMID: 15952895)
Nat Genet. 2002 Jun;31(2):141-9. (PMID: 11992124)
Cell. 2008 Dec 26;135(7):1201-12. (PMID: 19109892)
Genome Res. 2008 Oct;18(10):1652-9. (PMID: 18765822)
معلومات مُعتمدة: R01 ES017594 United States ES NIEHS NIH HHS; R01 ES017594-01 United States ES NIEHS NIH HHS
فهرسة مساهمة: Keywords: CpG island; DNA methylation; bisulfite sequencing; differential methylation hybridization; methylated CpG island recovery assay; methylated DNA immunoprecipitation; methylation profiling; methylation-sensitive SNP chip analysis; next-generation DNA sequencing
المشرفين على المادة: 0 (Biomarkers)
776B62CQ27 (Decitabine)
9007-49-2 (DNA)
EC 2.1.1.- (DNA Modification Methylases)
M801H13NRU (Azacitidine)
تواريخ الأحداث: Date Created: 20100608 Date Completed: 20120416 Latest Revision: 20211020
رمز التحديث: 20221213
مُعرف محوري في PubMed: PMC2880494
DOI: 10.2217/epi.09.31
PMID: 20526417
قاعدة البيانات: MEDLINE
الوصف
تدمد:1750-192X
DOI:10.2217/epi.09.31